ZEB2 and non-small cell lung carcinoma: In general, we purposed that the miR-6734-3p/ZEB2 axis might play an important role in regulating NSCLC progression and drug resistance, hence, the present study was designed to investigate the regulating effects and underlying mechanisms of this signal pathway in regulating NSCLC development and cisplatin-resistance, which will provide novel biomarkers for NSCLC diagnosis and treatment.